Total Payments
$51,328
2024 Payments
$3,626
Companies
78
Transactions
1,473
Medicare Patients
8,143
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$25,924 (50.5%)
Other$21,184 (41.3%)
Consulting$4,098 (8.0%)
Education$63.09 (0.1%)
Gifts$59.40 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,924 | 1,437 | 50.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,184 | 18 | 41.3% |
| Consulting Fee | $4,098 | 9 | 8.0% |
| Education | $63.09 | 8 | 0.1% |
| Gift | $59.40 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $24,403 | 251 | $0 (2024) |
| IBSA Pharma Inc. | $4,419 | 47 | $0 (2024) |
| Lilly USA, LLC | $2,957 | 158 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,508 | 83 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,461 | 75 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $1,434 | 46 | $0 (2024) |
| Mannkind Corporation | $1,215 | 73 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,206 | 64 | $0 (2024) |
| ABBVIE INC. | $1,066 | 63 | $0 (2024) |
| Insulet Corporation | $979.26 | 48 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,626 | 178 | Lilly USA, LLC ($532.81) |
| 2023 | $4,772 | 216 | Xeris Pharmaceuticals, Inc. ($665.38) |
| 2022 | $8,457 | 221 | Novo Nordisk Inc ($3,880) |
| 2021 | $15,350 | 196 | Novo Nordisk Inc ($10,718) |
| 2020 | $10,561 | 138 | Novo Nordisk Inc ($7,715) |
| 2019 | $3,418 | 201 | Novo Nordisk Inc ($485.10) |
| 2018 | $2,789 | 170 | Shire North American Group Inc ($349.33) |
| 2017 | $2,355 | 153 | Novo Nordisk Inc ($325.90) |
All Payment Transactions
1,473 individual payment records from CMS Open Payments — Page 1 of 59
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Automated insulin delivery system | ||||||
| 12/26/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Automated insulin delivery system | ||||||
| 12/20/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $24.01 | General |
| 12/17/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: ENDOCRINE AGENT | ||||||
| 12/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | VIVUS LLC | PANCREAZE (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | PFIZER INC. | SOMAVERT (Drug), GENOTROPIN | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 12/03/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $17.69 | General |
| Category: Endocrinology | ||||||
| 11/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $30.54 | General |
| Category: DIABETES | ||||||
| 11/25/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: DIABETES MEDICINE | ||||||
| 11/21/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/18/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: ENDOCRINE AGENT | ||||||
| 11/15/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/14/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Bone Health | ||||||
| 11/08/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Automated insulin delivery system | ||||||
| 11/08/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $20.06 | General |
| 11/06/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Endocrinology | ||||||
| 11/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Cardio-renal | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,168 | 20,278 | $1.6M | $533,949 |
| 2022 | 17 | 2,314 | 22,632 | $1.7M | $562,022 |
| 2021 | 18 | 1,890 | 20,261 | $1.5M | $493,175 |
| 2020 | 18 | 1,771 | 18,727 | $1.4M | $402,190 |
Total Patients
8,143
Total Services
81,898
Medicare Billing
$2.0M
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 193 | 17,520 | $805,920 | $324,545 | 40.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 521 | 784 | $270,480 | $76,333 | 28.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 203 | 285 | $133,380 | $40,150 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 280 | 362 | $85,070 | $26,465 | 31.1% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 193 | 293 | $70,320 | $17,076 | 24.3% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 157 | 167 | $61,623 | $14,765 | 24.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 60 | 60 | $40,800 | $9,437 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $43,821 | $9,427 | 21.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 112 | 263 | $39,450 | $7,259 | 18.4% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 31 | 32 | $24,000 | $3,612 | 15.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 192 | 239 | $2,151 | $2,008 | 93.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 25 | 25 | $5,550 | $1,252 | 22.6% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2023 | 25 | 26 | $5,200 | $1,171 | 22.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 95 | 141 | $1,410 | $449.40 | 31.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 201 | 19,441 | $894,286 | $334,790 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 648 | 1,051 | $362,595 | $100,482 | 27.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 154 | 240 | $112,320 | $34,184 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 300 | 394 | $92,590 | $27,037 | 29.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 205 | 329 | $78,960 | $20,132 | 25.5% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 121 | 130 | $47,970 | $11,443 | 23.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 143 | 345 | $51,750 | $9,614 | 18.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 39 | 39 | $26,520 | $7,340 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $26,509 | $5,857 | 22.1% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 30 | 31 | $23,250 | $3,633 | 15.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 12 | 33 | $4,125 | $1,411 | 34.2% |
About Dr. Lara Paraskos, MD
Dr. Lara Paraskos, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in South Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1912171075.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lara Paraskos, MD has received a total of $51,328 in payments from pharmaceutical and medical device companies, with $3,626 received in 2024. These payments were reported across 1,473 transactions from 78 companies. The most common payment nature is "Food and Beverage" ($25,924).
As a Medicare-enrolled provider, Paraskos has provided services to 8,143 Medicare beneficiaries, totaling 81,898 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location South Miami, FL
- Active Since 04/18/2008
- Last Updated 07/27/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1912171075
Products in Payments
- RYBELSUS (Drug) $8,474
- Ozempic (Drug) $6,810
- Tirosint (Drug) $4,349
- Saxenda (Drug) $4,051
- Rybelsus (Drug) $3,664
- JARDIANCE (Drug) $1,761
- AFREZZA (Drug) $1,215
- Wegovy (Drug) $992.83
- Omnipod (Device) $979.26
- BAQSIMI (Drug) $781.60
- GVOKE HYPOPEN (Drug) $668.63
- NATPARA (Drug) $627.10
- FARXIGA (Drug) $611.84
- BYDUREON (Drug) $567.71
- GVOKE PFS (Drug) $554.95
- UNITHROID (Drug) $545.72
- SYNTHROID (Drug) $538.79
- TRADJENTA (Drug) $489.11
- EVENITY (Biological) $485.99
- MOUNJARO (Drug) $473.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in South Miami
Julio Pita, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $18,761
Endocrinology, Diabetes & Metabolism $18,761
Bianca Alfonso, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $16,477
Endocrinology, Diabetes & Metabolism $16,477
Andreina Rojas, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $16,257
Endocrinology, Diabetes & Metabolism $16,257
Daisy Acevedo Morales, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $9,873
Endocrinology, Diabetes & Metabolism $9,873
Dr. Diane Krieger, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $3,223
Endocrinology, Diabetes & Metabolism $3,223
Nora Khoury
Endocrinology, Diabetes & Metabolism — Payments: $2,082
Endocrinology, Diabetes & Metabolism $2,082